Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
IBRX
IBRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest IBRX ETF News Today | Earnings, Events & Price Alerts
IBRX News
ImmunityBio Set to Announce Q4 Earnings with Mixed Estimates
12h ago
seekingalpha
ImmunityBio Earnings Preview and Market Reaction
3h ago
stocktwits
Top Performing Healthcare Stocks in March 2026
14h ago
seekingalpha
ImmunityBio's 2025 Outlook Shows Positive Trends
1d ago
stocktwits
Nvidia Reports Strong Earnings but Shares Decline
2d ago
Benzinga
ImmunityBio to Host Conference Call on March 3, 2026
3d ago
Newsfilter
ImmunityBio Sparks Retail Trader Speculation Ahead of Key Media Appearances
4d ago
stocktwits
ImmunityBio Completes Key Clinical Trial Enrollment
4d ago
Benzinga
ImmunityBio's ANKTIVA Trial Enrollment Completed Early
4d ago
stocktwits
ImmunityBio Completes Enrollment in Phase 2 Trial of ANKTIVA
4d ago
Newsfilter
Wall Street Opens Cautiously Amid China Market Concerns
5d ago
stocktwits
Patrick Soon-Shiong Reaffirms Control Over ImmunityBio with 66.3% Stake
5d ago
stocktwits
U.S. Markets Gained Ground on Wednesday, with Circle Internet Group Driving the Upward Trend
5d ago
Barron's
ImmunityBio Faces Increasing Short Pressure
5d ago
Benzinga
Trump's Remarks Ignite IBRX Stock Surge
6d ago
stocktwits
ImmunityBio's Anktiva Revenue Soars 700% in 2025
Feb 24 2026
stocktwits
Show More News
